- Ticker
- ACOU.ST
- Price
- 12.45
- Stock movement down
- -0.45 (-3.49%)
- Company name
- AcouSort AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 165.07M
- Ent value
- 148.84M
- Price/Sales
- 47.60
- Price/Book
- 7.45
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 53.84%
- 1 year return
- -26.23%
- 3 year return
- -18.98%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-04-09
DIVIDENDS
ACOU.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 47.60 |
| Price to Book | 7.45 |
| EV to Sales | 42.92 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 13.26M |
| EPS (TTM) | -1.09 |
| FCF per share (TTM) | -1.38 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.47M |
| Gross profit (TTM) | 755.00K |
| Operating income (TTM) | -14.39M |
| Net income (TTM) | -14.45M |
| EPS (TTM) | -1.09 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 21.77% |
| Operating margin (TTM) | -414.85% |
| Profit margin (TTM) | -416.64% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 19.02M |
| Net receivables | 1.57M |
| Total current assets | 21.95M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 24.94M |
| Accounts payable | 717.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.78M |
| Total liabilities | 2.78M |
| Shareholder's equity | 22.16M |
| Net tangible assets | 20.06M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -17.78M |
| Capital expenditures (TTM) | 506.00K |
| Free cash flow (TTM) | -18.28M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -65.21% |
| Return on Assets | -57.94% |
| Return on Invested Capital | -65.21% |
| Cash Return on Invested Capital | -82.51% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 12.90 |
| Daily high | 12.90 |
| Daily low | 12.00 |
| Daily Volume | 16K |
| All-time high | 31.61 |
| 1y analyst estimate | - |
| Beta | 1.01 |
| EPS (TTM) | -1.09 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACOU.ST | S&P500 | |
| Current price drop from All-time high | -60.62% | -0.85% |
| Highest price drop | -68.69% | -56.47% |
| Date of highest drop | 19 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -34.92% | -11.35% |
| Avg time to new high | 70 days | 13 days |
| Max time to new high | 600 days | 1805 days |
COMPANY DETAILS
Marketcap
165.07M
Marketcap category
Small-cap
Description
AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. AcouSort AB (publ) has collaboration agreement with global life science company to develop cell therapy. The company was founded in 2010 and is based in Lund, Sweden.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found